European Medicines Agency recommends Pfizer/BioNTech COVID-19 vaccine, (Comirnaty®), for conditional authorisation in the EU in people ≥ 16 years

EMA’s scientific opinion paves the way for first marketing authorisation of a COVID-19 vaccine in EU by European Commission with all the safeguards, controls and obligations this entails. Recommendation based on RCT (n=44,000) reporting 95% reduction in symptomatic COVID-19 cases

Source:

European Medicines Agency